Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021 FDA actively reviewing Company’s EUA submission for its first of its kind “at-home” Blood Collection kit used with the Biomerica COVID-19… Read More
Biomerica CE Mark COVID-19 Antigen Rapid Test
Download PDF
Biomerica Reports Fiscal 2021 1st Quarter Financial Results
Download PDF
Year End Results 2020 — September 1, 2020
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results Please Click Here for Press Release Safe Harbor Statement
Biomerica Announces Retirement of CFO
Biomerica Announces Retirement of CFO
Biomerica Announces Notice of Allowance
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVIS-10 antibody Tests Download PDF